Samsung Biologics stock price
삼성바이오로직스KRX:207940 · KOSPI · HealthcareToday's signals · MACD bullish cross
Signal details →Samsung Biologics last closed at ₩1,359,000 (-4.16%) on 2026-10-02. Signals today: MACD bullish cross. Listed on KOSPI. Trailing 12 months PER is 31.6×. Its overall grade ranks 102 of 306 stocks in Healthcare.
About this company
Samsung Biologics last closed at ₩1,359,000 (-4.16%) on 2026-10-02. Signals today: MACD bullish cross. Listed on KOSPI.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 102/306
Valuation grade F
Recent filings
DART · received recent list, not a complete filing history. Factual information, not investment advice.
Related stocks
- 로슈Customer
글로벌 대형 제약사로 삼성바이오로직스의 주요 위탁생산 고객군에 해당
- BMSCustomer
항체의약품 등 바이오의약품 위탁생산 수요가 큰 글로벌 제약사
- 아스트라제네카Customer
대형 바이오의약품 고객사로 CDMO 협력 가능성이 큰 글로벌 제약사
ETFs holding this stock
TIGER 바이오TOP10 · KIWOOM 의료AI · TIGER 200 헬스케어
Details →About Samsung Biologics
- What technical signals does Samsung Biologics (207940) have?
- Samsung Biologics current technical signals: MACD bullish cross.
- Is Samsung Biologics a cup-and-handle pattern?
- No. Samsung Biologics has no valid Cup signal right now.
- What published figures are available for Samsung Biologics?
- Market cap: KRW 63T. Trailing 12 months PER: 31.6×. Latest quarter PBR: 7.49×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Disclosed suppliers
2026-05-15 dataset
Turn what you saw on this name into a strategy
Ask Q about Samsung Biologics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.